RET ligand-2

RETligand-2 is a selective RET kinase inhibitor utilized as a key ligand for constructing PROTAC-based RET degraders with antitumor potential. It is also employed in the synthesis of compound RD-23 for research applications in oncology, including in vitro and in vivo studies.